BTC Class Might Not Happen Soon But FDA Working On Specific Proposal
Executive Summary
Stakeholders in the concept of creating a behind-the-counter status for some drugs are at loggerheads on the need for a BTC class but agree on one point - FDA will need a long time to reach a decision on the issue